Professor Ian Yang
Professor

Ian Yang

Email: 
Phone: 
+61 7 3139 5050

Background

Professor Ian Yang is a Thoracic Physician and Director of Thoracic Medicine at The Prince Charles Hospital, and Head of the PCH-Northside Clinical Unit, School of Clinical Medicine, Faculty of Medicine, The University of Queensland, Brisbane, Australia.

Availability

Professor Ian Yang is:
Available for supervision

Fields of research

Biomedical and Clinical Sciences Cardiovascular medicine and haematology Clinical sciences Oncology and carcinogenesis Respiratory diseases

Qualifications

  • Bachelor (Honours) of Medicine Surgery, The University of Queensland
  • Postgraduate Diploma, University of Newcastle
  • Doctor of Philosophy, The University of Queensland
  • Asian Pacific Society of Respirology, Asian Pacific Society of Respirology
  • Royal Australasian College of Physicians, Royal Australasian College of Physicians
  • The Thoracic Society of Australia and New Zealand, The Thoracic Society of Australia and New Zealand

Research interests

  • Clinical and translational research in chronic lung diseases

    Pathogenesis, diagnosis and treatment of chronic lung diseases, including COPD, asthma, lung cancer, mesothelioma and effects of air pollution

Research impacts

His clinical work is in the field of thoracic medicine, and his research team is studying gene-environmental interaction in COPD, asthma, lung cancer and air pollution. He is involved in the training of higher degree students in translational research into lung diseases.

He is a Chair of the National COPD Guidelines Committee of the Lung Foundation Australia, and a member of the COPD Coordinating Committee. He is Chair of the Medical Programs and Research Advisory Committee of the Asthma Foundation Queensland NSW.

Search Professor Ian Yang’s works on UQ eSpace

360 works between 1999 and 2025
All (360) Journal Article (265) Book Chapter (10) Conference Publication (84) Other Outputs (1)

321 - 340 of 360 works

2006

Journal Article

Association of asthma with a functional promoter polymorphism in the IL16 gene

Burkart, Kristin M., Barton, Sheila J., Holloway, John W., Yang, Ian A., Cakebread, Julie A., Cruikshank, William, Little, Frederic, Jin, Xiaoyi, Farrier, Lindsay A., Clough, Joanne B., Keith, Tim P., Holgate, Stephen, Center, David M. and O'Connor, George T. (2006). Association of asthma with a functional promoter polymorphism in the IL16 gene. Journal of Allergy And Clinical Immunologyhttp://espace.library.uq.edu.au/workflow/edit_metadata.php?id=234360&wfs_id=778, 117 (1), 86-91. doi: 10.1016/j.jaci.2005.10.011

Association of asthma with a functional promoter polymorphism in the IL16 gene

2006

Conference Publication

Beta1-adrenoceptor (AR) Arg389Gly polymorphisms affect responses to carvedilol in patients with idiopathic dilated cardiomyopathy

Chen, L., Meyers, D., Semmler, A.B., Yang, I., Pakorn, L., Lucas, M., Jovarsky, G., Savarimuthu, S., Galbraith, A., Parsonage, W. and Molenaar, P. (2006). Beta1-adrenoceptor (AR) Arg389Gly polymorphisms affect responses to carvedilol in patients with idiopathic dilated cardiomyopathy. 15th World Congress of Pharmacology, Beijing, China, 2nd - 7th July, 2006. China: Chinese Pharmacological Society.

Beta1-adrenoceptor (AR) Arg389Gly polymorphisms affect responses to carvedilol in patients with idiopathic dilated cardiomyopathy

2005

Journal Article

Mucociliary clearance in patients with chronic asthma: effects of beta agonists

Daviskas, Evangelia, Anderson, Sandra D., Shaw, Janet, Eberl, Stefan, Seale, J. Paul, Yang, Ian A. and Young, Iven H. (2005). Mucociliary clearance in patients with chronic asthma: effects of beta agonists. Respirology, 10 (4), 426-35. doi: 10.1111/j.1440-1843.2005.00738.x

Mucociliary clearance in patients with chronic asthma: effects of beta agonists

2005

Journal Article

Cochrane systematic reviews of treatments for lung cancer

Fong, K. M., Yang, I .A., Zimmerman, P. V. and Bowman, R. V. (2005). Cochrane systematic reviews of treatments for lung cancer. Respiratory Medicine, 99 (9), 1071-1078. doi: 10.1016/j.rmed.2005.05.002

Cochrane systematic reviews of treatments for lung cancer

2005

Journal Article

Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism

Larsen, Jill Everland, Colosimo, Maree Louise, Yang, Ian Anthony, Bowman, Rayleen, Zimmerman, Paul Victor and Fong, Kwun Meng (2005). Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism. Cancer Causes and Control, 16 (5), 579-585. doi: 10.1007/s10552-004-7842-3

Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism

2005

Book Chapter

Antiobiotics in chronic obstructive pulmonary disease, bronchiectasis and cystic fibrosis

Yang, I. A., Kim, S. T. and Bell, S. C. (2005). Antiobiotics in chronic obstructive pulmonary disease, bronchiectasis and cystic fibrosis. Evidence-based Respiratory Medicine. (pp. 389-414) edited by P. Gibson. Carlton South, Australia: Blackwell Publishing Asia. doi: 10.1002/9780470987377.ch30

Antiobiotics in chronic obstructive pulmonary disease, bronchiectasis and cystic fibrosis

2005

Journal Article

Effectiveness of hospital-based smoking cessation

Fung, Pamela R., Snape-Jenkinson, Stella L., Godfrey, Maureen T., Love, Keith W., Zimmerman, Paul V., Yang, Ian A. and Fong, Kwun M. (2005). Effectiveness of hospital-based smoking cessation. Chest, 128 (1), 216-223. doi: 10.1378/chest.128.1.216

Effectiveness of hospital-based smoking cessation

2005

Conference Publication

Gender difference in prevalence of non-cystic fibrosis bronchiectasis (NCFB) does not influence clinical phenotype

Kim, S. T., Passmore, L., Dent, A. G., Slaughter, R., Yang, I. A., Fong, K. M., Zimmerman, P. V. and Bell, S. C. (2005). Gender difference in prevalence of non-cystic fibrosis bronchiectasis (NCFB) does not influence clinical phenotype. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, 18-23 March, 2005. Carlton South, Victoria: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1

Gender difference in prevalence of non-cystic fibrosis bronchiectasis (NCFB) does not influence clinical phenotype

2005

Journal Article

β2-Adrenergic receptor polymorphism and asthma: True or false?

Holloway, J. W. and Yang, I. A. (2005). β2-Adrenergic receptor polymorphism and asthma: True or false?. Journal of Allergy And Clinical Immunology, 115 (5), 960-962. doi: 10.1016/j.jaci.2005.02.005

β2-Adrenergic receptor polymorphism and asthma: True or false?

2005

Conference Publication

Antibiotics for acute exacerbations of COPD: A systematic review

Yang, I. A., Kim, S. T. and Bell, S. C. (2005). Antibiotics for acute exacerbations of COPD: A systematic review. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, 18-23 March, 2005. Carlton South, Victoria: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1

Antibiotics for acute exacerbations of COPD: A systematic review

2005

Journal Article

Variation in the toll-like receptor 4 gene and susceptibility to myocardial infarction

Holloway, John, Yang, Ian and Ye, Shu (2005). Variation in the toll-like receptor 4 gene and susceptibility to myocardial infarction. Pharmacogenetics and Genomics, 15 (1), 15-21. doi: 10.1097/01213011-200501000-00003

Variation in the toll-like receptor 4 gene and susceptibility to myocardial infarction

2005

Conference Publication

Antibiotics in cystic fibrosis (CF): A systematic review

Kim, S. T., Yang, I. A. and Bell, S. C. (2005). Antibiotics in cystic fibrosis (CF): A systematic review. Array, Crete, Greece, 22-25 Jun, 2005. Amsterdam, Netherlands: Elsevier BV.

Antibiotics in cystic fibrosis (CF): A systematic review

2005

Journal Article

Association of tumor necrosis factor-alpha polymorphisms and ozone-induced change in lung function

Yang, Ian A., Holz, Olaf, Jorres, Rudolf A., Magnussen, Helgo, Barton, Sheila J., Rodriguez, Santiago, Cakebread, Julie A., Holloway, John W. and Holgate, Stephen T. (2005). Association of tumor necrosis factor-alpha polymorphisms and ozone-induced change in lung function. American Journal of Respiratory and Critical Care Medicine, 171 (2), 171-176. doi: 10.1164/rccm.200402-194OC

Association of tumor necrosis factor-alpha polymorphisms and ozone-induced change in lung function

2005

Conference Publication

Antibiotics in cystic fibrosis (CF): A systematic review

Kim, S. T., Yang, I. A. and Bell, S. C. (2005). Antibiotics in cystic fibrosis (CF): A systematic review. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, 18-23 March, 2005. Carlton South, Victoria: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1

Antibiotics in cystic fibrosis (CF): A systematic review

2005

Journal Article

Mucociliary clearance in patients with chronic asthma: Effects of beta(2) agonists

Daviskas, Evangelia, Anderson, Sandra D., Shaw, Janet, Eberl, Stefan, Seale, J. Paul, Yang, Ian A. and Young, Iven H. (2005). Mucociliary clearance in patients with chronic asthma: Effects of beta(2) agonists. Respirology, 10 (4), 426-435. doi: 10.1111/j.1440-1843.2005.00738.x/pdf

Mucociliary clearance in patients with chronic asthma: Effects of beta(2) agonists

2004

Journal Article

TLR4 Asp299Gly polymorphism is not associated with coronary artery stenosis (vol 170, pg 187, 2003)

Yang, I.A., Holloway, J.W. and Ye, S. (2004). TLR4 Asp299Gly polymorphism is not associated with coronary artery stenosis (vol 170, pg 187, 2003). Atherosclerosis, 173 (1), 155-155. doi: 10.1016/j.atherosclerosis.2003.11.001

TLR4 Asp299Gly polymorphism is not associated with coronary artery stenosis (vol 170, pg 187, 2003)

2004

Journal Article

Cytokine gene polymorphisms in idiopathic pulmonary fibrosis

Riha, R.L., Yang, I.A., Rabnott, G.C., Tunnicliffe, A.M., Fong, K.M. and Zimmerman, P.V. (2004). Cytokine gene polymorphisms in idiopathic pulmonary fibrosis. Internal Medicine Journal, 34 (3), 126-129. doi: 10.1111/j.1444-0903.2004.00503.x

Cytokine gene polymorphisms in idiopathic pulmonary fibrosis

2004

Journal Article

Toll-like receptor polymorphisms and allergic disease: interpreting the evidence from genetic studies

Yang, IA, Holgate, ST and Holloway, JW (2004). Toll-like receptor polymorphisms and allergic disease: interpreting the evidence from genetic studies. CLINICAL AND EXPERIMENTAL ALLERGY, 34 (2), 163-166. doi: 10.1111/j.1365-2222.2004.01893.x

Toll-like receptor polymorphisms and allergic disease: interpreting the evidence from genetic studies

2004

Journal Article

Toll-like receptor polymorphisms and allergic disease: interpreting the evidence from genetic studies

Yang, I. A., Holgate, S. T. and Holloway, J. W. (2004). Toll-like receptor polymorphisms and allergic disease: interpreting the evidence from genetic studies. Clinical & Experimental Allergy, 34 (2), 163-166. doi: 10.1111/j.1365-2222.2004.01893.x

Toll-like receptor polymorphisms and allergic disease: interpreting the evidence from genetic studies

2004

Journal Article

Characterization of two polymorphisms in the leukotriene C4 synthase gene in an Australian population of subjects with mild, moderate, and severe asthma

Kedda, MA, Shi, J, Duffy, D, Phelps, S, Yang, I, O'Hara, K, Fong, K and Thompson, PJ (2004). Characterization of two polymorphisms in the leukotriene C4 synthase gene in an Australian population of subjects with mild, moderate, and severe asthma. Journal of Allergy & Clinical Immunology, 113 (5), 889-895. doi: 10.1016/j.jaci.2004.02.008

Characterization of two polymorphisms in the leukotriene C4 synthase gene in an Australian population of subjects with mild, moderate, and severe asthma

Current funding

  • 2025 - 2027
    Extracellular-vesicles derived RNA biomarkers of lung cancer in never-smokers for early cancer detection
    Prince Charles Hospital Foundation
    Open grant
  • 2024 - 2026
    Changes in the lung microbiome with use of inhaled steroids in chronic obstructive pulmonary disease (COPD)
    Prince Charles Hospital Foundation
    Open grant
  • 2024 - 2025
    Lung Cancer Screening in Queensland
    Cancer Council Queensland
    Open grant
  • 2023 - 2026
    'Max Up' Trial - Maximising uptake of lung cancer screening and smoking cessation outcomes
    NHMRC MRFF EMCR - Early to Mid-Career Researchers
    Open grant
  • 2023 - 2025
    Transforming the care of people living with chronic obstructive pulmonary disease (COPD) using digital health
    Prince Charles Hospital Foundation
    Open grant
  • 2022 - 2026
    Defining the role and therapeutic manipulation of the gut-lung axis in respiratory disease (NHMRC Synergy administered by University of Technology Sydney)
    University of Technology Sydney
    Open grant
  • 2021 - 2025
    ACRF Lung Cancer Screening CENTRE OF EXCELLENCE (LUSCE)
    Australian Cancer Research Foundation
    Open grant
  • 2021 - 2026
    Lung cancer screening for early detection
    NHMRC MRFF EPCDR - Improving Diagnosis in Cancers with Low Survival Rates
    Open grant
  • 2021 - 2025
    Activating primary care COPD patients with Multi-morbidity (APCOM) study (MRFF Primary Health Care Research Grant led by Bond University)
    Bond University
    Open grant

Past funding

  • 2024 - 2025
    Cassette printer replacement (TPCHF Equipment Grant)
    Prince Charles Hospital Foundation
    Open grant
  • 2021 - 2023
    Inflammatory changes in 'onion skin' tissue layers surrounding the tumour site in lung cancer
    Prince Charles Hospital Foundation
    Open grant
  • 2020 - 2021
    TapeStation 4150
    Prince Charles Hospital Foundation
    Open grant
  • 2019 - 2020
    Inflammatory and DNA damage mechanisms in response to e-cigarette aerosols in COPD/lung cancer primary human bronchial epithelial cells
    Prince Charles Hospital Foundation
    Open grant
  • 2018 - 2020
    Extracellular vesicles as a novel biomarker for chronic obstructive pulmonary disease (COPD)
    Prince Charles Hospital Foundation
    Open grant
  • 2018 - 2024
    Dietary fibre and short chain fatty acids as immune regulators in COPD: a potential novel therapy
    Prince Charles Hospital Foundation
    Open grant
  • 2018 - 2019
    Bringing Modern Genomics to the Management of Lung Cancer in Queensland ( QGHA grant administered by QUT)
    Queensland University of Technology
    Open grant
  • 2017 - 2019
    Clinical trial validation of a blood exosome-prognosticator in lung cancer
    Prince Charles Hospital Foundation
    Open grant
  • 2017 - 2019
    Detection of microbial pathogens using quantitative polymerase chain reaction (qPCR) in patients with acute exacerbations of COPD
    Prince Charles Hospital Foundation
    Open grant
  • 2017 - 2021
    Testing the lung microbiome to predict risk of frequent exacerbations in COPD
    NHMRC Project Grant
    Open grant
  • 2016 - 2023
    ACRF Centre for Lung Cancer Early Detection
    Australian Cancer Research Foundation
    Open grant
  • 2016 - 2019
    Mobile health for COPD
    Prince Charles Hospital Foundation
    Open grant
  • 2016
    Using the lung microbiome to predict response to continuous antibiotics in COPD
    Australian Respiratory Council
    Open grant
  • 2015 - 2017
    SoM Leaders Research Support for Head Northside Clinical School
    Mayne Bequest Fund
    Open grant
  • 2014 - 2017
    The lung microbiome in coexisting COPD and bronchiectasis
    Prince Charles Hospital Foundation
    Open grant
  • 2014 - 2015
    Electronic Snapshot for Outpatient Management of COPD (ESO-COPD)
    Australian Centre for Health Services Innovation
    Open grant
  • 2013 - 2014
    Improving outcomes for patients with lung cancer and malignant mesothelioma
    Cancer Bequest Fund
    Open grant
  • 2013 - 2017
    PhD Scholarship in lung cancer - Funded by the Lung Foundation Australia/Neville Bantoft Bequest, with the UQ Thoracic Research Centre
    PhD Scholarship in Lung Cancer funded by the Lung Foundation Australia/Neville Bantoft Bequest
    Open grant
  • 2012 - 2017
    Clinical Academic Fellowship - Thoracic Physician
    Clinical Academic Fellowships
    Open grant
  • 2012 - 2017
    NHMRC Career Development Fellowship (Level 2): Preventing complications of chronic obstructive pulmonary disease
    NHMRC Career Development Award
    Open grant
  • 2012 - 2013
    Cigarette smoke and age-related epigenetic changes in the lung
    Prince Charles Hospital Foundation
    Open grant
  • 2012 - 2014
    Fundamental study into the role of the organic fraction on the toxicity of combustion generated airborne particles (ARC Discovery Project led by QUT)
    Queensland University of Technology
    Open grant
  • 2011 - 2012
    The Clinical Utility of High Resolution Melt Analysis in Detecting EGFR Mutations in the Serum of NSCLC Patients
    Pfizer Australia Pty Limited
    Open grant
  • 2011
    Tissue Culture Facility for the UQ Thoracic Research Centre
    NHMRC Equipment Grant
    Open grant
  • 2010 - 2011
    Novel microRNAs in pulmonary neoplasia
    Queensland Health
    Open grant
  • 2009 - 2012
    Mayne Bequest Fund Research Support Award: Thoracic Research
    Mayne Bequest Fund
    Open grant
  • 2009 - 2017
    Low dose CT screening for lung cancer
    Queensland Health Smart Health Research Grant
    Open grant
  • 2009 - 2012
    Genome-wide association study of protective alleles in lung cancer and chronic obstructive pulmonary disease
    Cancer Council Queensland
    Open grant
  • 2009 - 2015
    The AMAZES Study: Asthma and Macrolides: the AZithromycin Efficacy and Safety study (NHMRC Project Grant administered by University of Newcastle)
    University of Newcastle
    Open grant
  • 2008 - 2012
    Genomics of environmental stress and lung damage
    Queensland Health Smart Health Research Grant
    Open grant
  • 2007 - 2012
    Respiratory rehabilitation or self management for Chronic Obstructive Pulmonary Disease: what is the best management approach?
    Medical Benefits Fund of Australia Limited
    Open grant
  • 2007 - 2013
    Aberrant promoter methylation in lung cancer and smokers (TPCH)
    Queensland Health Smart Health Research Grant
    Open grant
  • 2007 - 2011
    Preventing progression of COPD
    NHMRC Career Development Award
    Open grant
  • 2006
    Innate Immunity genes in COPD
    Prince Charles Hospital Foundation
    Open grant
  • 2006
    Molecular pathways associated with the severity of COPD
    Prince Charles Hospital Foundation
    Open grant
  • 2006
    Slowing the Progression of Chronic Lung Disease
    Viertel Foundation (Sylvia and Charles Viertel)
    Open grant
  • 2006 - 2009
    The role of innate immunity genes in COPD
    NHMRC Project Grant
    Open grant
  • 2005 - 2006
    Innate immunity genes in asthma and allergy
    Asthma Foundation of Queensland
    Open grant

Availability

Professor Ian Yang is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Available projects

  • Diagnosis and treatment of chronic obstructive pulmonary disease

    Improving approaches to the early diagnosis, monitoring and management of patients with COPD

  • Lung ageing

    Genetics and epigenetics of ageing in the lung

  • The lung's response to air pollution

    Gene-environment interaction in the lung's response to exposure to air pollutants

Supervision history

Current supervision

  • Doctor Philosophy

    Biomarkers of lung cancer

    Principal Advisor

    Other advisors: Professor Kwun Fong

  • Master Philosophy

    Elastin turnover in the lung microenvironment and its significance in Lung Repair and Non-Small Cell Lung Carcinoma (NSCLC)

    Principal Advisor

  • Master Philosophy

    Elastin turnover in the lung microenvironment and its significance in Lung Repair and Non-Small Cell Lung Carcinoma (NSCLC)

    Principal Advisor

    Other advisors: Professor Kwun Fong

  • Master Philosophy

    A multivariable prediction model for osteoporotic fracture and low bone density in a lung cancer screening cohort

    Associate Advisor

    Other advisors: Professor Kwun Fong, Associate Professor Henry Marshall

  • Doctor Philosophy

    Precision medicine in the genomic era: emerging technologies for molecular profiling of lung cancer

    Associate Advisor

    Other advisors: Professor Kwun Fong

  • Doctor Philosophy

    Blood biomarkers for lung cancer screening

    Associate Advisor

    Other advisors: Professor Kwun Fong, Associate Professor Henry Marshall

  • Master Philosophy

    A multivariable prediction model for osteoporotic fracture in a lung cancer screening cohort

    Associate Advisor

    Other advisors: Professor Kwun Fong, Associate Professor Henry Marshall

  • Doctor Philosophy

    Molecular drivers of lung cancer.

    Associate Advisor

  • Doctor Philosophy

    Randomised pragmatic trial of comprehensive tissue sampling enabled by ultrathin bronchoscopic Radial probe EndoBronchial Ultrasound versus CT-guided TransThoracic needle aspiration/biopsy (REBUTT) for evaluation of peripheral pulmonary lesions.

    Associate Advisor

    Other advisors: Professor Kwun Fong

Completed supervision

Enquiries

For media enquiries about Professor Ian Yang's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au